Eton Pharmaceuticals, Inc. (ETON) Insider Trading -- Recent Executive & Director Transactions

7 insiders reported 31 Form 4 transactions for Eton Pharmaceuticals, Inc. (ETON) over the past 18 months (most recent 2026-07-07). Recent activity: Opaleye Management Inc. (Insider) Sell 65,000 shares, Opaleye Management Inc. (Insider) Sell 25,000 shares, Opaleye Management Inc. (Insider) Sell 10,000 shares, Opaleye Management Inc. (Insider) Sell 20,000 shares, Opaleye Management Inc. (Insider) Sell 6,685 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-07Opaleye Management Inc.InsiderSell65,000$2.4M
2026-07-07Opaleye Management Inc.InsiderSell25,000$934,628
2026-07-07Opaleye Management Inc.InsiderSell10,000$380,000
2026-07-07Opaleye Management Inc.InsiderSell20,000$767,456
2026-07-07Opaleye Management Inc.InsiderSell6,685$256,522
2026-06-17Adams Jennifer McKieDirectorBuy50,000$189,000
2026-06-17Adams Jennifer McKieDirectorSell50,000$1.6M
2026-05-29BRYNJELSEN SEANPresident & CEOSell119,852$3.8M
2026-05-29BRYNJELSEN SEANPresident & CEOSell148$4,835
2026-04-22RIEDEL NORBERT GDirectorBuy12,500$91,375
2026-04-22RIEDEL NORBERT GDirectorBuy19,655$169,230
2026-02-05RIEDEL NORBERT GDirectorBuy30,000$132,600
2026-01-14BRYNJELSEN SEANPresident & CEOSell5,015$77,181
2026-01-14Krempa DavidChief Business OfficerSell1,942$30,334
2026-01-14Gruber James R.Chief Financial OfficerSell2,293$35,473
2025-12-12Erdogan-Trinkaus IpekChief Commercial OfficerSell85$1,436
2025-12-12Gruber James R.Chief Financial OfficerSell4,542$77,169
2025-12-12BRYNJELSEN SEANPresident & CEOSell6,732$113,300
2025-12-12Krempa DavidChief Business OfficerSell6,264$106,488
2025-08-20Gruber James R.Chief Financial OfficerSell39,082$631,565
2025-08-20Gruber James R.Chief Financial OfficerSell2,631$42,149
2025-06-16Krempa DavidChief Business OfficerSell16,977$253,297
2025-06-16Krempa DavidChief Business OfficerSell6,800$100,436
2025-06-16Krempa DavidChief Business OfficerSell10,223$150,585
2025-06-12Opaleye Management Inc.InsiderBuy5,000$79,100

Source: SEC Form 4 filings · as of 2026-07-07